The Pennsylvania State University The Graduate School Intercollege Graduate Degree Program in Genetics EXPRESSION AND FUNCTION OF THE TUMOR SUPPRESSOR CANDIDATE HTRA1 IN HUMAN BREAST EPITHELIAL CELLS

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A BAC transgenic reporter recapitulates in vivo regulation of human telomerase reverse transcriptase in development and tumorigenesis

  2011cited by this paper
• Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications.

  2011cited by this paper
• Distinct biological roles for the akt family in mammary tumor progression.

  2010cited by this paper
• Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.

  2010cited by this paper
• Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

  2010cited by this paper
• Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer.

  2010cited by this paper
• EGFR Signaling and Drug Discovery

  2010cited by this paper
• Structure and function of SWI/SNF chromatin remodeling complexes and mechanistic implications for transcription.

  2010cited by this paper
• MicroRNAs and their target gene networks in breast cancer

  2010cited by this paper
• Immunohistochemical analysis of oxidative stress and DNA repair proteins in normal mammary and breast cancer tissues

  2010cited by this paper
• Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells.

  2010cited by this paper
• Serine protease HtrA1 expression in human hepatocellular carcinoma.

  2010cited by this paper
• Expression and Functional Significance of HtrA1 Loss in Endometrial Cancer

  2010cited by this paper
• ATM Activation by Oxidative Stress

  2010cited by this paper
• EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

  2010cited by this paper
• Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.

  2010cited by this paper
• The p400 ATPase regulates nucleosome stability and chromatin ubiquitination during DNA repair

  2010cited by this paper
• DNA methylation and cancer.

  2010cited by this paper
• Stress and the epigenetic landscape: a link to the pathobiology of human diseases?

  2010cited by this paper
• Normal stem cells and cancer stem cells: similar and different.

  2010cited by this paper
• Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer

  2010cited by this paper
• microRNA, cell cycle, and human breast cancer.

  2010cited by this paper
• Signaling mechanism(s) of reactive oxygen species in Epithelial-Mesenchymal Transition reminiscent of cancer stem cells in tumor progression.

  2010cited by this paper
• Epithelial–mesenchymal transition in cancer development and its clinical significance

  2010cited by this paper
• SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer

  2009cited by this paper
• Epigenetics, oxidative stress, and Alzheimer disease.

  2009cited by this paper
• Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation

  2009cited by this paper
• MicroRNAs Differentially Regulated by Akt Isoforms Control EMT and Stem Cell Renewal in Cancer Cells

  2009cited by this paper
• An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

  2009cited by this paper
• Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic.

  2009cited by this paper
• Targeting tumor angiogenesis with histone deacetylase inhibitors.

  2009cited by this paper
• DNA Damage Response Pathways in Tumor Suppression and Cancer Treatment

  2009cited by this paper
• Role of oxidative stress in cadmium toxicity and carcinogenesis.

  2009cited by this paper
• Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

  2009cited by this paper
• Identification of tubulins as substrates of serine protease HtrA1 by mixture‐based oriented peptide library screening

  2009cited by this paper
• Control of microRNA biogenesis by TGFbeta signaling pathway-A novel role of Smads in the nucleus.

  2009cited by this paper
• Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction.

  2009cited by this paper
• Overcoming Drug Resistance in Patients with Metastatic Breast Cancer

  2009cited by this paper
• The role of the ZEB family of transcription factors in development and disease

  2009cited by this paper
• Serine Protease HtrA1 Associates with Microtubules and Inhibits Cell Migration

  2009cited by this paper
• New tools for functional genomic analysis.

  2009cited by this paper
• New insights on oxidative stress in cancer.

  2009cited by this paper
• Cadmium Malignantly Transforms Normal Human Breast Epithelial Cells into a Basal-like Phenotype

  2009cited by this paper
• Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells

  2009cited by this paper
• FGFR2-related pathogenesis and FGFR2-targeted therapeutics (Review).

  2009cited by this paper
• Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

  2009cited by this paper
• Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

  2009cited by this paper
• Altered gene expression in breast cancer liver metastases

  2009cited by this paper
• Intracellular localization of the tumor suppressor HtrA1/Prss11 and its association with HPV16 E6 and E7 proteins

  2008cited by this paper
• Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination.

  2008cited by this paper
• Ageing, oxidative stress and cancer: paradigms in parallax

  2008cited by this paper
• Transcriptional regulation of cell polarity in EMT and cancer

  2008cited by this paper
• Reactive oxygen species and HIF-1 signalling in cancer.

  2008cited by this paper
• Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells

  2008cited by this paper
• PTP-Pez: A novel regulator of TGFβ signaling

  2008cited by this paper
• Sensitivity to Epidermal Growth Factor Receptor Inhibitor Requires E-Cadherin Expression in Urothelial Carcinoma Cells

  2008cited by this paper
• DNA methylation landscapes: provocative insights from epigenomics

  2008cited by this paper
• Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cells.

  2008cited by this paper
• Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer.

  2008cited by this paper
• Gene module level analysis: identification to networks and dynamics.

  2008cited by this paper
• Changes in mRNA and protein levels of human HtrA1, HtrA2 and HtrA3 in ovarian cancer.

  2008cited by this paper
• Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review).

  2008cited by this paper
• The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

  2008cited by this paper
• Oxidative stress, DNA methylation and carcinogenesis.

  2008cited by this paper
• Acetylated lysine 56 on histone H3 drives chromatin assembly after repair and signals for the completion of repair.

  2008cited by this paper
• How do real tumors become resistant to cisplatin?

  2008cited by this paper
• Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells.

  2008cited by this paper
• Assessment of DNA double-strand breaks and gammaH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone.

  2008cited by this paper
• Stems cells and the pathways to aging and cancer.

  2008cited by this paper
• Tight junction-based epithelial microenvironment and cell proliferation

  2008cited by this paper
• Aging and stem cell renewal

  2008cited by this paper
• Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

  2008cited by this paper
• Elevated expression of serine protease HtrA1 in preeclampsia and its role in trophoblast cell migration and invasion.

  2008cited by this paper
• FACT-mediated exchange of histone variant H2AX regulated by phosphorylation of H2AX and ADP-ribosylation of Spt16.

  2008cited by this paper
• Profiling microRNA expression with microarrays.

  2008cited by this paper
• Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

  2008cited by this paper
• Changes in expression of serine proteases HtrA1 and HtrA2 during estrogen-induced oxidative stress and nephrocarcinogenesis in male Syrian hamster.

  2008cited by this paper
• Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

  2008cited by this paper
• Genome-wide analysis of DNA methylation patterns

  2007cited by this paper
• The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes

  2007cited by this paper
• Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

  2007cited by this paper
• TGF‐β signaling: A tale of two responses

  2007cited by this paper
• Methods of DNA methylation analysis

  2007cited by this paper
• A proximal activator of transcription in epithelial-mesenchymal transition.

  2007cited by this paper
• Adaptation versus selection: the origins of metastatic behavior.

  2007cited by this paper
• NF-κB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2

  2007cited by this paper
• Molecular definition of breast tumor heterogeneity.

  2007cited by this paper
• Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition*

  2007cited by this paper
• Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines

  2007cited by this paper
• Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

  2007cited by this paper
• The epigenomics of cancer.

  2007cited by this paper
• ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage

  2007cited by this paper
• Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

  2007cited by this paper
• Interfering with disease: a progress report on siRNA-based therapeutics

  2007cited by this paper
• Aging Hematopoietic Stem Cells Decline in Function and Exhibit Epigenetic Dysregulation

  2007cited by this paper
• Identification and expansion of human colon-cancer-initiating cells

  2007cited by this paper
• Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells.

  2007cited by this paper
• Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

  2007cited by this paper
• Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells

  2007cited by this paper
• American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer.

  2007cited by this paper

• No citing papers are available for this paper.